Related Overviews


'RU486' can also refer to...





RU 486

RU 486


Regulation of Cre Recombinase Activity by the Synthetic Steroid RU 486

Endocrinology: Effect of mifepristone (RU486) on the pituitary response to gonadotrophin releasing hormone in women

Mifepristone (RU486) and voluntary termination of pregnancy: enigmatic variations* or anecdotal religion-based attitudes?

Disparate actions of mifepristone (RU 486) on glands and stroma in the primate endometrium

The effect of RU486 on the gene expression profile in an endometrial explant model

RU486 inhibits synthesis of an endogenous inhibitor of cell arachidonate release from choriodecidua tissue.

The nuclear factor-κB pathway is involved in matrix metalloproteinase-9 expression in RU486-induced endometrium breakdown in mice

Implantation and early pregnancy: Effect of single-dose, early luteal phase administration of mifepristone (RU486) on implantation stage endometrium in the rhesus monkey

Effects of luteal phase administration of mifepristone (RU486) and prostaglandin analogue or inhibitor on endometrium in the rhesus monkey.

The effect of a single dose of mifepristone (RU486) on the fine structure of the human endometrium during the early luteal phase.

Preimplantation embryo morphology following early luteal phase anti-nidatory treatment with mifepristone (RU486) in the rhesus monkey

Evaluation of a Tier I Screening Battery for Detecting Endocrine-Active Compounds (EACs) Using the Positive Controls Testosterone, Coumestrol, Progesterone, and RU486


More Like This

Show all results sharing this subject:

  • Chemistry


Show Summary Details

Quick Reference


mifepristone; 11β‐(4‐dimethylaminophenyl)‐17β‐hydroxy‐17α‐prop‐1‐ynylestra‐4, 9‐dien‐3‐one; a steroidal progesterone‐receptor antagonist that prevents implantation of a fertilized ovum in the uterus. It is an effective contraceptive even when taken after coitus.

Subjects: Chemistry.

Reference entries

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.